In the tumor microenvironment, particularly in cancers such as prostate cancer, AR signaling can inhibit NF-κB activity to exert anti-inflammatory effects, while NF-κB activation can suppress AR signaling, promoting cell survival and growth [17,18]. The gene discussed is NFKB1; the disease is cancer.